How would you rank them w/ a generalist offer for FT IBD analyst? Or unclear w/out looking at specific groups?
Trending Content - Investment Banking Forum
| +191 | Evercore > Goldman and I don’t think it’s particularly close anymore | 66 | 1h |
| +158 | Article: Why UBS's Asian M&A bankers are thriving and UBS's American M&A bankers are not | 17 | 1d |
| +90 | Think Twice before Recruiting for HOUSTON IB!! | 46 | 25m |
| +86 | UBS Offer Day | 32 | 7h |
| +71 | I hate Wells Fargo | 19 | 1d |
| +52 | No return offer - feeling like a failure is an understatement | 21 | 14h |
| +49 | How cooked am I as an incoming WF IB SA 2027? | 17 | 1d |
| +47 | WF Return offers | 28 | 3d |
| +40 | 2026 Investment Banking Return Offer Climate | 25 | 1d |
| +39 | Should I go back into a junior IBD role for comp? | 16 | 3d |
Career Resources
impossible you have an offer at all 4, just wait..
Have offers at 2
Broadstbully is right - there's no point of us comparing CS vs BAML if you only have offers at DB and Barclays (just as an example). Wait until you have your offers lined up and a better idea of which groups you'd likely get placed in so that this conversation can be more constructive.
All that being said, congrats on the offers.
Very tough without groups but personally I'd view this as BAML/CS (group dependent) > Barclays > DB
At the same time, I'd choose DB LevFin over a weak group at Barclays. Or CS Sponsors over a weak BAML group. etc. etc.
Ask HR which groups are actually hiring and what number. By now all summers should have accepted/declined their offers so HR will have visibility as to what groups are taking analysts and which are full. Then make your decision.
a bit curious about your ranking. CS has been getting hit hard, and they've dropped on league tables (lowest of all of these), Barclays has just had an incredible number of senior people leave the firm and am surprised that they're still afloat and doing well in the league tables, I'd imagine that this would end soon. DB is doing fine, and BAML is doing well. I'd say if you can get into one of Sponsors, M&A, or Lev Fin at DB, you're best off taking that offer over all of these other than perhaps BAML M&A (I don't believe sponsors/lev fin coverage there is as strong).
BAML has several strong groups that would be my #1 in this scenario. Best Lev Fin and C&R on the street, great M&A, and great healthcare.
It may be that in a year or two DB is stronger than Barclays/CS. As of now, CS and Barclays are stronger. Few banks are really scaling back right now because M&A activity is increasing. But yes, DB may have more longevity, and it does have a great Lev Fin group.
Sapiente molestiae est laudantium veritatis facere recusandae distinctio. Qui odio ducimus nam. Sapiente delectus tempore debitis ut fuga ex quam.
Asperiores alias repudiandae fugiat rem cum magni blanditiis. Quia velit possimus enim omnis iste dolor.
Aut est animi quia et earum ea nobis blanditiis. Nulla nihil possimus iure blanditiis earum et. Esse quis optio harum rerum.
Voluptatibus assumenda qui itaque earum. Ad assumenda id molestiae praesentium vero. Ipsa omnis nesciunt aut rerum. Animi molestias in corrupti dolore.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...